Industry Overview

US medical robotics market was valued at $9.02 billion in 2025 and is projected to reach $36.81 billion by 2035, growing at a CAGR of 15.18% during the forecast period (2026–2035). The US medical robotics market is expanding as hospitals and care providers prioritize technologies that enhance precision, safety, and workflow efficiency. Demand is rising across surgical, rehabilitative, and therapy-support systems as clinicians seek tools that reduce variability in clinical outcomes. Strong investment from healthcare networks, coupled with steady improvements in robotic platforms, is accelerating system replacements and multi-specialty adoption. Companies are introducing more adaptable, data-enabled systems that integrate smoothly with existing hospital infrastructure. The market is further benefiting from wider clinical acceptance as procedure volumes grow and training programs become more accessible. Together, these factors are shaping a more technology-driven care environment across the US.

Market Dynamics

Rising Precision in Surgical Robotics  

The US continues to see strong momentum in surgical robotic systems as hospitals seek more consistent outcomes in high-complexity procedures. Adoption is fueled by growing utilization in urology, orthopedics, and general surgery, where robotics supports reduce complications and recovery time. The companies are expanding training centers and service support to support hospitals in accelerating deployment. Hospitals are increasingly shifting toward multi-robot strategies to cover a broader range of procedures. Technological upgrades, including enhanced imaging and AI-driven guidance, are improving accuracy in the operating room. These developments are positioning robotic surgery as a core component of advanced surgical care across the country.

Expanding Role of Rehabilitative Robotics  

Rehabilitative robotic systems are gaining attention as US providers look to improve therapy consistency for patients recovering from neurological and mobility-related conditions. Growth is supported by rising demand for personalized rehabilitation solutions and the ability of robotics to offer repeatable, data-driven therapy sessions. Manufacturers are introducing lighter, more adaptive devices designed for both hospitals and outpatient therapy settings. Digital tracking features are enabling therapists to monitor patient performance with greater precision. Collaborative programs among research centers and technology companies are accelerating clinical validation. As these systems mature, they are becoming a valuable asset in long-term recovery planning across the US.

Market Segmentation

• Based on the product, the market is segmented into surgical robotic systems, rehabilitative robotic systems, noninvasive radiosurgery robots, hospital & pharmacy robotic systems, and others.

Surgical Robotic Systems Segment to Lead the Market with the Largest Share

Demand for surgical robotic platforms in the US is rising as hospitals focus on improving precision in complex interventions. Growth is supported by increasing use in general surgery, orthopaedics, and oncology, where robotic tools support reducing variability in clinical outcomes. Key companies are strengthening their footprint through new consoles, expanded training networks, and collaborative clinical programs. Many hospitals are adopting multi-system setups to widen the range of procedures they can cover. Recent upgrades in real-time imaging and smarter instrument control are enhancing surgeon confidence. These shifts are gradually embedding robotic assistance into routine surgical planning across major care centres.

Evolution of Rehabilitative Robotics: A Key Segment in Market Growth

Rehabilitative robotic solutions are gaining traction as US providers look to streamline therapy for stroke, spinal injuries, and age-related mobility issues. The segment is benefiting from greater awareness of personalized rehabilitation and the measurable progress these systems deliver. The manufacturers are introducing lighter exoskeletons and more adaptive therapy platforms suited for both clinical and community settings. Data-driven features, including performance dashboards, are helping therapists refine recovery pathways. Pilot programs with academic and rehabilitation institutions are supporting validation for wider adoption. As these technologies mature, they are becoming a practical extension of long-term care strategies for diverse patient groups.

Market Players Outlook

The major companies operating in the US medical robotics market include Intuitive Surgical, Inc., Medtronic Inc., Stryker Corp., Zimmer Biomet Holdings, Inc., and Boston Scientific Corp., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Developments

• In November 2025, Fortis Memorial Research Institute (FMRI) unveiled Hembot, the first life-sized humanoid robot meant for healthcare settings. The robot is built on the NVIDIA Jetson Orin platform and, capable of 100 trillion AI operations per second. It was introduced to demonstrate how humanoid systems may support hospitals in areas such as patient guidance, navigation, clinical information support, monitoring assistance, and general engagement in OPDs and waiting areas within clinical settings.

• In October 2025, Johnson & Johnson MedTech announced advancements in developing the company’s robotics systems with physical AI technologies that create simulated environments to accelerate future product innovation, optimize clinical workflows, and improve training for clinical teams.

• In October 2025, Microbot Medical partnered with a US-based third-party logistics (3PL) company to support the commercialization of the FDA-cleared LIBERTY System. The Company is expected to initiate the limited market release of the LIBERTY System during the current fourth quarter of 2025, with the broader launch anticipated to occur in April 2026.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the US Medical Robotics market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.